personalized medicine

Research in Review

Immunotherapy Better Than Standard of Care for Type of DLBCL

08/03/2017

JCP Editors

Single-agent immunotherapy in patients with a subtype of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) provides more clinical benefit than conventional therapy, according to research published in...

...

08/03/2017

Journal of Clinical Pathways

Research in Review

Novel Ovarian Cancer Subtypes Associated With Survival Outcomes Following Surgery

08/02/2017

JCP Editors

High-grade serous ovarian cancer can be categorized in five molecular subtypes associated with survival and surgical outcomes, according to research published in Clinical Cancer Research (August...

...

08/02/2017

Journal of Clinical Pathways

Research in Review

Cancer Symptoms More Important Than Diagnosis for Palliative Care

07/27/2017

JCP Editors

Results of a recent survey showed that for patients with cancer requiring palliative care, some symptoms and care needs are not strongly associated with specific diagnoses, published in Supportive Care in Cancer...

...

07/27/2017

Journal of Clinical Pathways

Research in Review

NSCLC Prognostic Index Considers Personal Characteristics to Better Predict Outcomes

07/26/2017

JCP Editors

The Lung Cancer Prognostic Index provides personalized and disease-specific prognostic information for patients with non-small cell lung cancer (NSCLC) and may result in better survival outcomes, according to a...

The...

07/26/2017

Journal of Clinical Pathways

Research in Review

Novel Prognostic Index Designed for Patients With MZL

07/19/2017

JCP Editors

A new prognostic tool improves personalized treatment for patients with marginal zone lymphoma (MZL), according to recent research published in Blood (online July 2017;...

A new...

07/19/2017

Journal of Clinical Pathways

Research in Review

Model Predicts Tumor Spread in Lung Cancer

07/17/2017

JCP Editors

Genetic characteristics of lung cancer can be used to predict likelihood of metastasis, a newly developed model shows. ----- Related Content Leptomeningeal Metastases More Common in EGFR+ Lung Cancer Best...

...

07/17/2017

Journal of Clinical Pathways

Research in Review

PD-L2 Expression May Indicate Response to Immunotherapy in Head and Neck Cancer

06/15/2017

JCP Editors

A recent study suggests that immunotherapies targeting both PD-L1 and PD-L2 may enhance response rates for patients with head and neck squamous cell carcinoma (HNSCC), published in Clinical Cancer Research (published...

A...

06/15/2017

Journal of Clinical Pathways

Research in Review

Panel Highlights Uses of Genomic Testing for Breast Cancer

06/07/2017

JCP Editors

A panel of breast cancer experts offered an education session on the value of standard and genomic testing for breast cancer at the 2017 American Society of Clinical Oncology Annual Meeting (June 2-6, 2017; Chicago,...

A...

06/07/2017

Journal of Clinical Pathways

Research in Review

CAR T-Cells May Have Therapeutic Value in Solid Cancers

06/07/2017

JCP Editors

Chimeric antigen receptor (CAR) T-cells may elicit responses in solid cancers by inducing cancer cell death and the release of tumor antigens that could stimulate T-cell activity, according to research presented at...

...

06/07/2017

Journal of Clinical Pathways

Research in Review

Financial Benefit of NGS Varies by Patient, Disease Type in Community Settings

06/01/2017

JCP Editors

Next-generation sequencing (NGS) may be economically beneficial for select patients with treated in the community oncology setting, but it should be carefully applied due to potential associated financial burdens,...

...

06/01/2017

Journal of Clinical Pathways